GRI
Price
$0.75
Change
-$0.02 (-2.60%)
Updated
Dec 20, 04:59 PM (EDT)
IDYA
Price
$25.61
Change
+$0.82 (+3.31%)
Updated
Dec 20, 04:59 PM (EDT)
100 days until earnings call
Ad is loading...

GRI vs IDYA

Header iconGRI vs IDYA Comparison
Open Charts GRI vs IDYABanner chart's image
GRI Bio
Price$0.75
Change-$0.02 (-2.60%)
Volume$6.52K
CapitalizationN/A
IDEAYA Biosciences
Price$25.61
Change+$0.82 (+3.31%)
Volume$32.17K
CapitalizationN/A
GRI vs IDYA Comparison Chart
Loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRI vs. IDYA commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a Hold and IDYA is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (GRI: $0.74 vs. IDYA: $25.61)
Brand notoriety: GRI and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 4% vs. IDYA: 219%
Market capitalization -- GRI: $6.61M vs. IDYA: $2.21B
GRI [@Biotechnology] is valued at $6.61M. IDYA’s [@Biotechnology] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • GRI’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, GRI is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 2 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • GRI’s TA Score: 2 bullish, 6 bearish.
  • IDYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than GRI.

Price Growth

GRI (@Biotechnology) experienced а -7.50% price change this week, while IDYA (@Biotechnology) price change was +1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

GRI is expected to report earnings on May 10, 2023.

IDYA is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.21B) has a higher market cap than GRI($6.61M). IDYA YTD gains are higher at: -28.021 vs. GRI (-97.888). GRI has higher annual earnings (EBITDA): -7.87M vs. IDYA (-220.54M). IDYA has more cash in the bank: 920M vs. GRI (4.75M). GRI has less debt than IDYA: GRI (131K) vs IDYA (18.8M). IDYA has higher revenues than GRI: IDYA (3.92M) vs GRI (0).
GRIIDYAGRI / IDYA
Capitalization6.61M2.21B0%
EBITDA-7.87M-220.54M4%
Gain YTD-97.888-28.021349%
P/E Ratio0.01N/A-
Revenue03.92M-
Total Cash4.75M920M1%
Total Debt131K18.8M1%
FUNDAMENTALS RATINGS
GRI: Fundamental Ratings
GRI
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRIIDYA
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISSC8.150.65
+8.67%
Innovative Solutions and Support
ARCC21.380.25
+1.18%
Ares Capital Corp
NPK93.450.70
+0.75%
National Presto Industries
CENTA33.82-0.38
-1.11%
Central Garden & Pet Company
ALZN1.11-0.14
-11.20%
Alzamend Neuro Inc.

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
-3.90%
IDYA - GRI
54%
Loosely correlated
+3.31%
NLSP - GRI
38%
Loosely correlated
-18.07%
GOVX - GRI
37%
Loosely correlated
-1.29%
INAB - GRI
36%
Loosely correlated
+3.49%
SNSE - GRI
34%
Loosely correlated
+4.63%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+3.31%
GRI - IDYA
54%
Loosely correlated
-3.90%
PLRX - IDYA
47%
Loosely correlated
-0.68%
PGEN - IDYA
47%
Loosely correlated
+5.07%
INAB - IDYA
47%
Loosely correlated
+3.49%
RCKT - IDYA
46%
Loosely correlated
+1.85%
More